Neonatal Intensive Care Market Research Report Information, By Product, By End-User And by Region Industry Forecast Till 2032
¼¼°èÀÇ ½Å»ý¾Æ ÁýÁßÄ¡·á ½ÃÀå ±Ô¸ð´Â 2023³â 98¾ï 6,000¸¸ ´Þ·¯, 2024³â 104¾ï 9,000¸¸ ´Þ·¯¿¡¼ ¿¹Ãø ±â°£ Áß 6.22%ÀÇ CAGR·Î ÃßÀÌÇϸç, 2032³â¿¡´Â 170¾ï ´Þ·¯ ±Ô¸ð·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
Á¶»êÀº ½É°¢ÇÑ °øÁߺ¸°Ç ¹®Á¦·Î ½Å»ý¾Æ ÁýÁßÄ¡·á ½ÃÀåÀ» ÁÖµµÇϰí ÀÖÀ¸¸ç, WHO¿¡ µû¸£¸é 2020³â¿¡´Â ¾à 1,340¸¸ ¸íÀÇ ¾Æ±â°¡ Á¶»êÀ¸·Î ž °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Á¶»ê Áõ°¡´Â »ê¸ðÀÇ °Ç° »óÅÂ, ¶óÀÌÇÁ½ºÅ¸ÀÏ ¼±ÅÃ, »çȸ°æÁ¦Àû »óÅ µî ´Ù¾çÇÑ º¯¼ö¿¡ ±âÀÎÇϸç, ÀÌ´Â ½Å»ý¾Æ Ä¡·á ¼ºñ½ºÀÇ °³¼±À» ¿ä±¸Çϰí ÀÖ½À´Ï´Ù.
Á¶»ê Áõ°¡ÀÇ ÁÖ¿ä ¿øÀÎÀº °íÀ§Çè ÀÓ½ÅÀÔ´Ï´Ù. ´Ù¸¥ À§Çè ¿äÀÎÀ¸·Î´Â °í·É Ãâ»ê µîÀÌ ÀÖ½À´Ï´Ù. ÀÌ ±×·ìÀÇ ¸¹Àº ¿©¼ºµéÀº ´õ ¸¹Àº ÀÇÇÐÀû ¾î·Á¿òÀ» °Þ°í ÀÖÀ¸¸ç, Á¶»êÀÇ °¡´É¼ºÀ» ³ôÀÔ´Ï´Ù. ¶ÇÇÑ ÀÌ ±×·ìÀÇ ¿©¼ºÀº 35¼¼ ÀÌ»óÀÏ °æ¿ì°¡ ¸¹À¸¸ç, °íÇ÷¾Ð, ´ç´¢º´°ú °°Àº °Ç° ¹®Á¦¸¦ °¡Áö°í ÀÖ´Â °æ¿ì°¡ ¸¹¾Æ Á¶»êÀÇ À§ÇèÀÌ ³ô¾ÆÁý´Ï´Ù. µÎ ¹øÂ° À§Çè ¿äÀÎÀº ´ÙÅ ÀÓ½ÅÀÔ´Ï´Ù. ´ÙÅÂÀÓ½ÅÀº º¸Á¶»ý½Ä¼ú ÀÌ¿ëÀÌ Áõ°¡ÇÏ¸é¼ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â Á¶»êÀÇ °¡´É¼ºÀ» ³ôÀÔ´Ï´Ù.
Áö¿ªº° ÀλçÀÌÆ®
2023³â ½ÃÀå Á¡À¯À²Àº ºÏ¹Ì°¡ °¡Àå Å« ±Ô¸ð¸¦ º¸À̰í ÀÖÀ¸¸ç, ¼ºÀå·ü¿¡¼´Â ¾Æ½Ã¾ÆÅÂÆò¾çÀÌ ¿¹Ãø ±â°£ Áß 9.84%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î °¡Àå Å« ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
ºÏ¹Ì ½ÃÀåÀº ºü¸£°Ô ¼ºÀåÇϰí ÀÖÀ¸¸ç, »ê¸ðÀÇ °Ç° ºÒ¾È, ¶óÀÌÇÁ½ºÅ¸ÀÏ ¼±ÅÃ, ´ÙÅ ÀӽŠµî ´Ù¾çÇÑ ¿äÀÎÀ¸·Î ÀÎÇØ Á¶»êÀÌ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½Å»ý¾Æ °Ç°¿¡ ´ëÇÑ ÀνÄÀÇ Çâ»ó°ú ÀÇ·á±â¼úÀÇ ¹ßÀüÀº ½Å»ý¾Æ Ä¡·áÀÇ °³¼±¿¡ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÇ·á ¼ºñ½º ¹× ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÁöÃâ Áõ°¡´Â ½Å»ý¾Æ ÁýÁß Ä¡·áÀÇ º¸±ÞÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
À¯·´ ½ÃÀåÀº ½Å»ý¾Æ °Ç°¿¡ ´ëÇÑ ´ëÁßÀÇ ÀνÄÀÌ ³ô¾ÆÁö°í Àü¹®Àû Ä¡·áÀÇ Á߿伺ÀÌ ³ô¾ÆÁö¸é¼ NICU ¼ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ ºü¸£°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½Å»ý¾Æ ¿ëǰÀº ³ôÀº ±â¼ú Çõ½ÅÀÌ Æ¯Â¡À̸ç, ±× °á°ú ȯÀÚÀÇ ¿¹Èİ¡ °³¼±µÇ°í ÀÖ½À´Ï´Ù.
Àεµ, Áß±¹ µî ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¸Å¿ì ³ôÀº Ãâ»êÀ²À» À¯ÁöÇϰí ÀÖÀ¸¸ç, ½Å»ý¾Æ ÀÀ±Þ½Ã¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½Å»ý¾Æ ÀÇ·á¿¡ Á¤ÅëÇÏ°í °íµµ·Î ÈÆ·ÃµÈ ½Å»ý¾Æ Àü¹®ÀÇ¿Í ÀÇ·á Àü¹®°¡ÀÇ ¼ö°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, Áß±¹ ¹× µ¿³²¾Æ½Ã¾Æ µîÀÇ ±¹°¡¿¡¼ ¹Î°£ º´¿ø°ú ÀÇ·á ½Ã¼³ÀÌ ºü¸£°Ô È®ÀåµÊ¿¡ µû¶ó ½Å»ý¾Æ ÁýÁßÄ¡·á½Ç(NICU)¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù.
¼¼°èÀÇ ½Å»ý¾Æ ÁýÁßÄ¡·á ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀåÀÇ Á¤ÀÇ¿Í °³¿ä, ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ °¢Á¾ ¿µÇâ¿äÀÎ ºÐ¼®, ½ÃÀå ±Ô¸ð ÃßÀÌ¡¤¿¹Ãø, °¢Á¾ ±¸ºÐ¡¤Áö¿ª/ÁÖ¿ä ±¹°¡º° ³»¿ª, °æÀï ȯ°æ, ÁÖ¿ä ±â¾÷ÀÇ °³¿ä µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
¸ñÂ÷
Á¦1Àå °³¿ä
Á¦2Àå ½ÃÀå °³¿ä
Á¦3Àå Á¶»ç ¹æ¹ý
Á¦4Àå ½ÃÀå ¿ªÇÐ
- ÃËÁø¿äÀÎ
- Á¶»êÀÇ ¹ß»ý·ü »ó½Â
- ½Å»ý¾Æ ÄÉ¾î ±â¼úÀÇ Áøº¸
- ¾ïÁ¦¿äÀÎ
- ±âȸ
- ¿¬±¸°³¹ß¿¡ ´ëÇÑ ÅõÀÚÀÇ Áõ°¡
Á¦5Àå ½ÃÀå ¿äÀÎ ºÐ¼®
- Porter's Five Forces ºÐ¼®
- COVID-19 ÀÌÀü ½Ã³ª¸®¿À
- COVID-19 Áß ½Ã³ª¸®¿À
- COVID-19 ÀÌÈÄ ½Ã³ª¸®¿À
Á¦6Àå ¼¼°èÀÇ ½Å»ý¾Æ ÁýÁßÄ¡·á ½ÃÀå : Á¦Ç°º°
- °³¿ä
- º¸À°±â
- ¿ÀÇÂÇü
- Ŭ·ÎÁîÇü
- ¿î¼Û¿ë
- º¸¿Â±â ºÎÂø(ÄÁ¹öÅͺí À¯´Ö)
- º¸¿Â±â
- RADIANT WARMERS
- Æ®·£½ºÆ÷Æ® º¸¿Â±â
- ±âŸ
- È£Èí±â ±â±â
- ¼Ò»ý±â
- ÀΰøÈ£Èí±â
- CPAP ¸Ó½Å
- »ê¼Ò ¿ä¹ý ±â±â
- ºÎ¼Óǰ
- ±¤¼± ¿ä¹ý Àåºñ
- ¼ö¼ú ¹× ¸ð´ÏÅ͸µ Àåºñ
- C¾Ï ¸Ó½Å
- Á¦¼¼µ¿±â
- ¸¶Ãë±â
- ½ÉÀå ¸ð´ÏÅÍ
- ÆÞ½º¿Á½Ã¹ÌÅÍ
- ¿Âµµ ¸ð´ÏÅÍ
- Àúü¿Â ¿ä¹ý(HIE) Àåºñ
- ÅÂ¾Æ ¸ð´ÏÅ͸µ Àåºñ
- ±âŸ
Á¦7Àå ¼¼°èÀÇ ½Å»ý¾Æ ÁýÁßÄ¡·á ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°
- °³¿ä
- º´¿ø
- »ê¸ð-ÅÂ¾Æ ÀÇ·á ¼¾ÅÍ
Á¦8Àå ¼¼°èÀÇ ½Å»ý¾Æ ÁýÁßÄ¡·á ½ÃÀå : Áö¿ªº°
- °³¿ä
- ºÏ¹Ì
- À¯·´
- µ¶ÀÏ
- ÇÁ¶û½º
- ¿µ±¹
- ÀÌÅ»¸®¾Æ
- ½ºÆäÀÎ
- ±âŸ
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- Àεµ
- ±âŸ Áö¿ª
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- ¶óƾ¾Æ¸Þ¸®Ä«
Á¦9Àå °æÀï ±¸µµ
- ½ÃÀå Á¡À¯À² ºÐ¼®
- °æÀï ´ë½Ãº¸µå
- °ø°³ ±â¾÷ÀÇ ÁÖ½Ä °³¿ä
- ºñ±³ ºÐ¼® : ÁÖ¿ä ±â¾÷ÀÇ À繫 µ¿Çâ
- ÁÖ¿ä °³¹ß¡¤¼ºÀå Àü·«
Á¦10Àå ±â¾÷ °³¿ä
- GE HEALTHCARE
- KONINKLIJKE PHILIPS N.V.
- SCHILLER HEALTHCARE INDIA PVT. LTD.
- MINDRAY
- DRAGERWERK AG & CO. KGAA
- NIHON KOHDEN CORPORATION
- MEDTRONIC
- SHENZHEN COMEN MEDICAL INSTRUMENTS CO., LTD.
- FANEM
- NATUS
- BISTOS CO., LTD.
- GINEVRI
- NINGBO DAVID MEDICAL DEVICE CO., LTD
- BPL MEDICAL TECHNOLOGIES
- NARANG MEDICAL LIMITED
- ATOM MEDICAL CORPORATION
Á¦11Àå µ¥ÀÌÅÍ Àοë
KSA
Neonatal Intensive Care Market Research Report Information, By Product (Incubator, Warmer, Respiratory Equipment, Phototherapy Equipment, Surgical & Monitoring Equipment), By End-User (Hospitals, and Maternal-Fetal Medicine Centers) And by Region (North America, Europe, Asia-Pacific, And Rest of The World) Industry Forecast Till 2032
Market Overview
In 2023, the Neonatal Intensive Care Market was estimated at USD 9.86 billion. The market is expected to expand from USD 10.49 billion in 2024 to USD 17.0 billion by 2032, with a compound annual growth rate (CAGR) of 6.22% over the forecast period (2024-2032). Rising preterm birth rates and developments in neonatal care technology are driving market expansion.
Preterm births are a serious public health concern and have driven the Neonatal Intensive Care Market. According to the WHO, preterm birth occurs before 37 weeks of gestation, and around 13.4 million babies were born prematurely in 2020. The rising occurrence of preterm births is due to a variety of variables, including maternal health, lifestyle choices, and socioeconomic status, all of which demand improved newborn care services.
The primary reason of the growth in preterm births is high-risk pregnancies. Other risk factors include advanced maternal age; most women in this group have more medical difficulties, which increases their chance of preterm delivery. These women are often 35 years or older, making them more susceptible to health issues such as hypertension or diabetes, all of which increase the risk of having a preterm baby. A second risk factor is multiple pregnancies, which are becoming more prevalent as people use assisted reproductive technologies, increasing the chance of premature delivery.
Market Segment insights
The Neonatal Intensive Care Market is divided into several product categories, including incubators, warmers, respiratory equipment, phototherapy equipment, and surgical and monitoring equipment.
The Neonatal Intensive Care Market is divided into two segments based on the end user: hospitals and maternal-fetal medicine centers.
Regional insights
The Neonatal Intensive Care Market has been classified by region: North America, Europe, Asia-Pacific, India, and the Rest of the World. North America held the biggest market share in 2023. However, Asia-Pacific is expected to develop at the fastest CAGR of 9.84% over the forecast period.
The Neonatal Intensive Care Market in North America is quickly expanding, indicating a considerable increase in premature deliveries caused by a variety of factors such as maternal health concerns, lifestyle choices, and multiple pregnancies. Furthermore, improved awareness of newborn health and advances in healthcare techniques help to improve neonatal care. Additionally, increased spending on healthcare services and infrastructure promotes the spread of neonatal intensive care.
The Neonatal Intensive Treatment Market in Europe is expanding rapidly, driven by rising public awareness of neonatal health and the significance of specialist treatment, which boosts demand for NICU services. Furthermore, neonatal items feature a high level of technological innovation, resulting in better patient outcomes.
The Asia-Pacific area, which includes countries such as India and China, continues to have a very high birth rate, fueling the demand for neonatal critical care services. In addition, the growing number of highly trained neonatologists and healthcare professionals with expertise in neonatal care, as well as the rapid expansion of private hospitals and healthcare facilities in countries such as China and Southeast Asia, are improving access to neonatal intensive care units (NICUs).
Major Players
Major participants in the Neonatal Intensive Care Market are GE Healthcare, Koninklijke Philips N.V., Dragerwerk AG & Co. KGaA, Nihon Kohden, Medtronic Plc, Shenzhen Comen Medical Instruments Co., Ltd. (China), Fanem (Brazil), and Natus (US).
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
- 2.1 DEFINITION
- 2.1 SCOPE OF THE STUDY
- 2.2 RESEARCH OBJECTIVE
- 2.3 MARKET STRUCTURE
3 RESEARCH METHODOLOGY
- 3.1 OVERVIEW
- 3.2 DATA FLOW
- 3.2.1 DATA MINING PROCESS
- 3.3 PURCHASED DATABASE:
- 3.4 SECONDARY SOURCES:
- 3.4.1 SECONDARY RESEARCH DATA FLOW:
- 3.5 PRIMARY RESEARCH:
- 3.5.1 PRIMARY RESEARCH DATA FLOW:
- 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
- 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE
- 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
- 3.6.1 REVENUE ANALYSIS APPROACH
- 3.7 DATA FORECASTING
- 3.7.1 DATA FORECASTING TECHNIQUE
- 3.8 DATA MODELING
- 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
- 3.8.2 DATA MODELING:
- 3.9 TEAMS AND ANALYST CONTRIBUTION
4 MARKET DYNAMICS
- 4.1 INTRODUCTION
- 4.2 DRIVERS
- 4.2.1 RISING INCIDENCE OF PRETERM BIRTHS
- 4.2.2 ADVANCEMENTS IN NEONATAL CARE TECHNOLOGY
- 4.3 RESTRAINTS
- 4.3.1 HIGH COSTS OF NEONATAL CARE
- 4.4 OPPORTUNITY
- 4.4.1 GROWING INVESTMENT IN RESEARCH AND DEVELOPMENT
5 MARKET FACTOR ANALYSIS
- 5.1 PORTER'S FIVE FORCES MODEL
- 5.1.1 THREAT OF NEW ENTRANTS
- 5.1.2 BARGAINING POWER OF SUPPLIERS
- 5.1.3 THREAT OF SUBSTITUTES
- 5.1.4 BARGAINING POWER OF BUYERS
- 5.1.5 INTENSITY OF RIVALRY
- 5.2 PRE-COVID-19 SCENARIO
- 5.2.1 TECHNOLOGICAL ADVANCEMENTS
- 5.2.2 HEALTHCARE TRENDS SUPPORTING GLOBAL NEONATAL INTENSIVE CARE MARKET
- 5.2.3 REGIONAL INSIGHTS
- 5.2.3.1 NORTH AMERICA
- 5.2.3.2 EUROPE
- 5.2.3.3 ASIA-PACIFIC
- 5.2.3.4 MIDDLE EAST & AFRICA
- 5.2.4 FAVOURABLE GOVERNMENT SCENARIO
- 5.2.5 OTHERS
- 5.3 DURING COVID-19 SCENARIO
- 5.3.1 IMPACT ON NEONATAL CARE DELIVERY
- 5.3.2 SUPPLY CHAIN DISRUPTIONS
- 5.3.3 FINANCIAL STRAIN
- 5.3.4 OTHERS
- 5.4 POST COVID-19 SCENARIO
- 5.4.1 OVERVIEW OF SALES DECLINE
- 5.4.2 IMPACT OF COVID-19 ON GLOBAL NEONATAL INTENSIVE CARE MARKET RESOURCES CONSIDERING FINANCIAL, HUMAN, MATERIAL, AND OPERATIONAL
- 5.4.3 IMPACT ON GOVERNMENT TENDERS FOR NEONATAL EQUIPMENT AND OTHER PUBLIC PROCUREMENT OPPORTUNITIES RELATED TO NEONATAL EQUIPMENT
- 5.4.4 OTHERS
6 GLOBAL NEONATAL INTENSIVE CARE MARKET, BY PRODUCT
- 6.1 OVERVIEW
- 6.2 INCUBATOR
- 6.2.1 OPEN INCUBATOR
- 6.2.2 CLOSED INCUBATOR
- 6.2.3 TRANSPORT INCUBATOR
- 6.2.4 WARMER-CUM-INCUBATOR (CONVERTIBLE UNIT)
- 6.3 WARMER
- 6.3.1 RADIANT WARMERS
- 6.3.2 TRANSPORT WARMERS
- 6.3.3 OTHERS
- 6.4 RESPIRATORY EQUIPMENT
- 6.4.1 RESUSCITATOR
- 6.4.2 VENTILATOR
- 6.4.3 CPAP MACHINES
- 6.4.4 OXYGEN THERAPY DEVICES
- 6.4.5 ACCESSORIES
- 6.5 PHOTOTHERAPY EQUIPMENT
- 6.5.1 BILI LIGHTS
- 6.5.2 ACCESSORIES
- 6.6 SURGICAL AND MONITORING EQUIPMENT
- 6.6.1 C-ARM MACHINE
- 6.6.2 DEFIBRILLATOR
- 6.6.3 ANESTHESIA MACHINE
- 6.6.4 CARDIAC MONITORS
- 6.6.5 PULSE OXIMETERS
- 6.6.6 TEMPERATURE MONITORS
- 6.6.7 THERAPEUTIC HYPOTHERMIA (HIE) EQUIPMENT
- 6.6.8 FETAL MONITORING EQUIPMENT
- 6.6.8.1 EXTERNAL FETAL MONITORS
- 6.6.8.2 INTERNAL FETAL MONITORS
- 6.6.9 OTHERS
7 GLOBAL NEONATAL INTENSIVE CARE MARKET, BY END USER
- 7.1 OVERVIEW
- 7.2 HOSPITALS
- 7.3 MATERNAL-FETAL MEDICINE CENTERS
8 GLOBAL NEONATAL INTENSIVE CARE MARKET, BY REGION
- 8.1 OVERVIEW
- 8.2 NORTH AMERICA
- 8.2.1 US
- 8.2.2 CANADA
- 8.2.3 MEXICO
- 8.3 EUROPE
- 8.3.1 GERMANY
- 8.3.2 FRANCE
- 8.3.3 UK
- 8.3.4 ITALY
- 8.3.5 SPAIN
- 8.3.6 REST OF EUROPE
- 8.4 ASIA PACIFIC
- 8.4.1 CHINA
- 8.4.2 JAPAN
- 8.4.3 AUSTRALIA
- 8.4.4 SOUTH KOREA
- 8.4.5 REST OF ASIA PACIFIC
- 8.5 INDIA
- 8.6 REST OF THE WORLD
- 8.6.1 MIDDLE EAST & AFRICA
- 8.6.2 LATIN AMERICA
9 COMPETITIVE LANDSCAPE
- 9.1 INTRODUCTION
- 9.2 MARKET SHARE ANALYSIS,
- 9.3 COMPETITOR DASHBOARD
- 9.4 PUBLIC PLAYERS STOCK SUMMARY
- 9.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
- 9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
- 9.6.1 AQUISITION
- 9.6.2 RECOGNITION
- 9.6.3 EXPANSION
10 COMPANY PROFILES
- 10.1 GE HEALTHCARE
- 10.1.1 COMPANY OVERVIEW
- 10.1.2 FINANCIAL OVERVIEW
- 10.1.3 PRODUCT OFFERED
- 10.1.4 KEY DEVELOPMENTS
- 10.1.5 SWOT ANALYSIS
- 10.1.6 KEY STRATEGIES
- 10.2 KONINKLIJKE PHILIPS N.V.
- 10.2.1 COMPANY OVERVIEW
- 10.2.2 FINANCIAL OVERVIEW
- 10.2.3 PRODUCTS OFFERED
- 10.2.4 KEY DEVELOPMENTS
- 10.2.5 SWOT ANALYSIS
- 10.2.6 KEY STRATEGIES
- 10.3 SCHILLER HEALTHCARE INDIA PVT. LTD.
- 10.3.1 COMPANY OVERVIEW
- 10.3.2 FINANCIAL OVERVIEW
- 10.3.3 PRODUCTS OFFERED
- 10.3.4 KEY DEVELOPMENTS
- 10.3.5 KEY STRATEGIES
- 10.4 MINDRAY
- 10.4.1 COMPANY OVERVIEW
- 10.4.2 FINANCIAL OVERVIEW
- 10.4.3 PRODUCTS OFFERED
- 10.4.4 KEY DEVELOPMENTS
- 10.4.5 SWOT ANALYSIS
- 10.4.6 KEY STRATEGIES
- 10.5 DRAGERWERK AG & CO. KGAA
- 10.5.1 COMPANY OVERVIEW
- 10.5.2 FINANCIAL OVERVIEW
- 10.5.3 PRODUCTS OFFERED
- 10.5.4 KEY DEVELOPMENTS
- 10.5.5 SWOT ANALYSIS
- 10.5.6 KEY STRATEGIES
- 10.6 NIHON KOHDEN CORPORATION
- 10.6.1 COMPANY OVERVIEW
- 10.6.2 FINANCIAL OVERVIEW
- 10.6.3 PRODUCTS OFFERED
- 10.6.4 KEY DEVELOPMENTS
- 10.6.5 KEY STRATEGIES
- 10.7 MEDTRONIC
- 10.7.1 COMPANY OVERVIEW
- 10.7.2 FINANCIAL OVERVIEW
- 10.7.3 PRODUCTS OFFERED
- 10.7.4 KEY DEVELOPMENTS
- 10.7.5 SWOT ANALYSIS
- 10.7.6 KEY STRATEGIES
- 10.8 SHENZHEN COMEN MEDICAL INSTRUMENTS CO., LTD.
- 10.8.1 COMPANY OVERVIEW
- 10.8.2 FINANCIAL OVERVIEW
- 10.8.3 PRODUCTS OFFERED
- 10.8.4 KEY DEVELOPMENTS
- 10.8.5 KEY STRATEGIES
- 10.9 FANEM
- 10.9.1 COMPANY OVERVIEW
- 10.9.2 FINANCIAL OVERVIEW
- 10.9.3 PRODUCTS OFFERED
- 10.9.4 KEY DEVELOPMENTS
- 10.9.5 KEY STRATEGIES
- 10.10 NATUS
- 10.10.1 COMPANY OVERVIEW
- 10.10.2 FINANCIAL OVERVIEW
- 10.10.3 PRODUCTS OFFERED
- 10.10.4 KEY DEVELOPMENTS
- 10.10.5 KEY STRATEGIES
- 10.11 BISTOS CO., LTD.
- 10.11.1 COMPANY OVERVIEW
- 10.11.2 FINANCIAL OVERVIEW
- 10.11.3 PRODUCTS OFFERED
- 10.11.4 KEY DEVELOPMENTS
- 10.11.5 KEY STRATEGIES
- 10.12 GINEVRI
- 10.12.1 COMPANY OVERVIEW
- 10.12.2 FINANCIAL OVERVIEW
- 10.12.3 PRODUCTS OFFERED
- 10.12.4 KEY DEVELOPMENTS
- 10.12.5 KEY STRATEGIES
- 10.13 NINGBO DAVID MEDICAL DEVICE CO., LTD
- 10.13.1 COMPANY OVERVIEW
- 10.13.2 FINANCIAL OVERVIEW
- 10.13.3 PRODUCTS OFFERED
- 10.13.4 KEY DEVELOPMENTS
- 10.13.5 KEY STRATEGIES
- 10.14 BPL MEDICAL TECHNOLOGIES
- 10.14.1 COMPANY OVERVIEW
- 10.14.2 FINANCIAL OVERVIEW
- 10.14.3 PRODUCTS OFFERED
- 10.14.4 KEY DEVELOPMENTS
- 10.14.5 KEY STRATEGIES
- 10.15 NARANG MEDICAL LIMITED
- 10.15.1 COMPANY OVERVIEW
- 10.15.2 FINANCIAL OVERVIEW
- 10.15.3 PRODUCTS OFFERED
- 10.15.4 KEY DEVELOPMENTS
- 10.15.5 KEY STRATEGIES
- 10.16 ATOM MEDICAL CORPORATION
- 10.16.1 COMPANY OVERVIEW
- 10.16.2 FINANCIAL OVERVIEW
- 10.16.3 PRODUCTS OFFERED
- 10.16.4 KEY DEVELOPMENTS
- 10.16.5 SWOT ANALYSIS
- 10.16.6 KEY STRATEGIES
11 DATA CITATIONS